Templemars, France

Geneviève Cordonnier

This inventor holds 3 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignee: Genfit. Active years: 2022-2024.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.1

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Geneviève Cordonnier: Innovator in Non-Invasive Diagnostics

Introduction

Geneviève Cordonnier is a prominent inventor based in Templemars, France. She has made significant contributions to the field of medical diagnostics, particularly in non-invasive methods for liver disease detection. With a total of 3 patents, her work is paving the way for advancements in healthcare.

Latest Patents

Cordonnier's latest patents include innovative methods for diagnosing non-alcoholic steatohepatitis (NASH). The first patent focuses on a novel method for diagnosing NASH and classifying subjects as potential candidates for treatment. The second patent presents a non-invasive diagnostic approach for non-alcoholic fatty liver diseases, including NASH and liver fibrosis. These inventions are crucial for improving patient outcomes and reducing the need for invasive procedures.

Career Highlights

Geneviève Cordonnier is associated with Genfit, a company dedicated to developing innovative solutions for liver diseases. Her expertise and dedication to research have positioned her as a key figure in the medical diagnostics field.

Collaborations

Cordonnier has collaborated with notable professionals in her field, including John Brozek and Fouad Ben Sudrik. These partnerships enhance the impact of her work and contribute to the advancement of medical technology.

Conclusion

Geneviève Cordonnier's contributions to non-invasive diagnostics are significant and transformative. Her innovative patents are set to improve the diagnosis and treatment of liver diseases, showcasing her commitment to advancing healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…